Guidance Document a Critique of Pharmacokinetics and Biological Monitoring

  • Delmont C. Eberhart
Part of the NATO · Challenges of Modern Society book series (NATS, volume 19)


The purpose of this discussion is to critique the OECD Guidance Document entitled: “The Conduct of Field Studies to Evaluate the Exposure of Operators, Workers and Bystanders to Pesticides” with respect to pharmacokinetics and biological monitoring.


Biological Monitoring Pesticide Exposure Dermal Exposure Human Metabolism Systemic Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Carmichael, N.G., Nolan, R.J., Perkins, J.M., Davies, R., and Warrington, S.J., 1989, Oral and dermal pharmacokinetics of triclopyr in human volunteers, Human Toxicol. 8: 431–437.CrossRefGoogle Scholar
  2. Chester, G., 1993, Evaluation of worker exposure to, and absorption of, pesticides during occupational use and crop re-entry. Ann. Occ. Hyg. 37 (5): 509–523.CrossRefGoogle Scholar
  3. Chester, G., 1995, The Conduct of Field Studies to Evaluate the Exposure of Operators, Workers and Bystanders to Pesticides, in: “Proceedings of the Workshop on Methods of Pesticide Exposure Assessment, October 5–8, 1993”, Ottawa.Google Scholar
  4. Chester, G., Hatfield, L.D., Hart, T.B., Leppert, B.C., Swaine, H., and Tummon, O.J., 1987, Worker exposure to, and absorption of, cypermethrin during aerial application of an “ultra low volume” formulation to cotton, Arch. Environ. Contam. Toxicol. 16: 69–78.PubMedCrossRefGoogle Scholar
  5. Chester, G., and Hart, T.B., 1986, Biological monitoring of a herbicide applied through backpack and vehicle sprayers, Toxicol. Lett. 33: 137–149.PubMedCrossRefGoogle Scholar
  6. Dubelman, S., and Cowell, J.E., 1989, Biological monitoring technology for measurement of applicator exposure, in: “Biological Monitoring for Pesticide Exposure,” R.G.M. Wang, C.A. Franklin, R.C. Honeycutt, and J.C. Reinert, eds. ACS Symp. Ser. No 382: 240–250, American Chemical Society, Washington, D.C.CrossRefGoogle Scholar
  7. Eberhart, D., Halvorson, M., and Parkinson, A., 1989, Species differences in the in vitro glucuronidation of digitoxin (dt,) and digitoxigenin monodigitoxoside (dt,), The Toxicologist 9: 32.Google Scholar
  8. Eberhart, D., Gemzik, B., Halvorson, M., and Parkinson, A., 1991, Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin, Mol. Pharm. 40: 859–867.Google Scholar
  9. Hackathom, D. R., and Eberhart, D. C., 1985, Data-base proposal for use in predicting mixer/loader-applicator exposure. in: “Dermal Exposure Related to Pesticide Use: Discussion of Risk Assessment,” R.C. Honeycutt, G. Zweig, and N.N. Ragsdale, eds, ACS Symp. Ser. 273: 34–355, American Chemical Society, Washington, D.C.Google Scholar
  10. Hayes, W.J., 1985, Ethical considerations involving studies of pesticides and other xenobiotics in man, in: “IUPAC Pesticide Chemistry: Human Welfare and the Environment. Mode of Action, Metabolism and Toxicity,” J. Miyamoto, ed., Pergamon, London, 387–394.Google Scholar
  11. Miyamoto, J., Kaneko, H., Hutson, D.H., Esser, H.O., Gorbach, S., and Dorn, E., 1988, “IUPAC. Pesticide Metabolism: Extrapolation from Animals to Man,” Blackwell Scientific Publications, London.Google Scholar
  12. Nolan, R.J., Rick, D.L., Freshour, N.L., and Saunders, J.H., 1984, Chlorpyrifos: pharmacokinetics in human volunteers, Toxicol. Applied Pharmacol. 73: 8–15.CrossRefGoogle Scholar
  13. Ramsey, J.D., Woollen, B.H., Auton, T.R., Batten, P.L., and Leeser, J.E., 1992, Pharmacokinetics of fluazifop-butyl in human volunteers II: Dermal dosing, Human Exp. Toxicol. 11: 247–254.CrossRefGoogle Scholar
  14. Woollen, B.H., 1993, Biological monitoring for pesticide absorption. Ann. Occ. Hyg. 37 (5): 525–540.CrossRefGoogle Scholar
  15. Woollen, B.H., Marsh, J.R., Laird, W.J.D., and Lesser, J.E., 1992, The metabolism of cypermethrin in man: Differences in urinary metabolite profiles following oral and dermal administration, Xenobiotica 22 (8): 983–991.PubMedCrossRefGoogle Scholar
  16. Woollen, B.H., Hart, T.B., Batten, P.L., Laird, W.J.D., Davies, D.S., and Dollery, C.T., 1991, Oral pharmacokinetics of fluazifop-hutyl in human volunteers, Human Exp. Toxicol. 10: 39–43.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Delmont C. Eberhart
    • 1
  1. 1.Product Safety Section Research and Development DepartmentMILES Inc. Agriculture DivisionKansas CityUSA

Personalised recommendations